Please assess the completion status of the following clinical trial:

Trial Title: Acupuncture or Medication in Reducing Pain in Postmenopausal Women With Breast Cancer and Joint Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Diagnosis of breast cancer~* Concurrent therapy with anastrozole for the adjuvant treatment of breast cancer~* Must have moderate or worse arthralgia, as defined by a baseline WOMAC pain scale score ≥ 48~  * Patients with other underlying pain syndromes (e.g., osteoarthritis) are eligible, but the arthralgia must have worsened since starting anastrozole~* Hormone receptor-positive disease~PATIENT CHARACTERISTICS:~* Post-menopausal status meeting the following criteria:~  * At least 12 months without spontaneous menstrual bleeding~ * History of bilateral salpingo-oophorectomy with or without hysterectomy~ * Age \> 55 with hysterectomy with or without oophorectomy~ * Age \< 55 with hysterectomy without oophorectomy or with unknown status, and serum FSH in post-menopausal range within the past 4 weeks~* Not needle phobic~* Patients with a contraindication to NSAIDs (i.e., prior gastrointestinal bleed secondary to NSAIDs or severe renal insufficiency) are eligible, but will be treated with alternative analgesics such as narcotics or acetaminophen~PRIOR CONCURRENT THERAPY:~* See Disease Characteristics~* Concurrent chronic narcotics or NSAIDs allowed, but doses must be stable for ≥ the past month~* Concurrent antidepressant medications allowed, but doses must be stable for ≥ the past 3 months~* At least 6 months since prior acupuncture~* No prior acupuncture for aromatase inhibitor-associated pain syndrome

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm I (Type: EXPERIMENTAL): Patients undergo acupuncture for 20-30 minutes, on the appropriate pain points on the anterior portion of the body alternating with posterior portion of the body, thrice weekly for 2 weeks and then twice weekly for 3 weeks.
- Arm II (Type: ACTIVE_COMPARATOR): Patients receive standard-of-care analgesics (i.e., NSAIDs, narcotics, acetaminophen, or other) for 5 weeks. Patients not responding to analgesia may cross over to arm I.

Based on this trial design, predict the completion outcome and termination type (if applicable).